If you are living with Multiple Sclerosis (MS), you are likely familiar with the cycle of trying different treatments, hoping for relief, and feeling a sense of defeat when something—like physiotherapy—doesn't yield the results you were promised. I’ve spent nine years behind the scenes in NHS clinics, watching patients navigate these referral pathways, and I know exactly how exhausting it is to feel like you’re hitting a brick wall.
One of the questions I am asked most frequently is whether medical cannabis is an option for MS spasticity after conventional treatments have failed. It is a complex landscape, often clouded by confusing terminology and "miracle cure" marketing. Let’s strip away the noise and look at how the system actually works in the UK.
The One-Sentence Takeaway: Medical cannabis is not a "first-line" treatment, so if you haven't exhausted established, NICE-approved conventional options for your spasticity, a specialist is unlikely to consider it.
The "Confusing Phrases" List: What Your Doctor Actually Means
In my years in admin, I kept a mental (and sometimes written) list of the phrases that make patients feel like they are being brushed off. Here is what they actually mean when you hear them in a consultation:
- "Last Resort": This doesn't mean "giving up." It means that you have documented evidence that you’ve tried every major, safer, and cheaper conventional medication or therapy recommended by NICE, and they didn't work. "Specialist Oversight": This means your GP cannot sign this off. You need a consultant who is on the General Medical Council (GMC) Specialist Register for your specific condition (Neurology) to take clinical responsibility for your prescription. "Clinical Judgement": This is code for "there is no fixed list." Doctors make decisions based on your unique history, not by ticking a box on a menu.
The UK Legal Framework: Since November 2018
It is important to remember that the legal landscape for cannabis-based products for medicinal use (CBPMs) changed in November 2018. Before this, these products were effectively locked behind extremely rigid research constraints. Now, specialist doctors can prescribe them. However, "can prescribe" is very different from "will prescribe."
The law change did not create a "green light" for everyone with a diagnosis. Instead, it moved the decision-making power from a rigid national policy to the individual consultant. This is why you cannot simply find a clinic and demand a prescription; you must prove that your case meets the standard of clinical necessity.
Dispelling the Myth of the "Fixed List"
One of the biggest frustrations I see in patient forums is people asking: "Is MS on the list of conditions that qualify for cannabis?"
There is no "official fixed list." If a clinic website promises you that your condition qualifies you automatically, walk away. That is "salesy clinic talk," and it is misleading. Eligibility is entirely based on evidence-based recommendations and the clinical judgement of a specialist. A doctor must evaluate whether, in your specific case, the potential benefits of cannabis outweigh the potential risks (such as cognitive side effects or interactions with your existing MS medication).
Why Physio Alone Usually Isn't Enough
You asked: "Can I qualify if physio didn’t help?" The honest answer is: Physio is rarely the only thing they check.
NICE guidance (the gold standard https://smoothdecorator.com/why-do-people-say-there-is-no-fixed-list-for-medical-cannabis-uk/ for UK healthcare) expects to see that you have engaged with the conventional "ladder" of MS spasticity treatments. Typically, a specialist will want to see that you have tried, at a minimum, two distinct conventional treatments for your spasticity. These might include:
Baclofen or Gabapentin (or other oral antispasmodics). Physiotherapy and occupational therapy interventions. Other muscle relaxants or pharmacological interventions appropriate for your specific MS progression.If you have only tried physiotherapy and nothing else, most specialists will point you back to the "conventional" route first. They need a documented history of treatment failure to justify prescribing a treatment that remains outside the standard NHS pathway for most patients.
The Specialist Clinician Assessment: What Happens Next?
When you book a consultation with a specialist, they aren't just looking at your diagnosis; they are looking at your treatment history. To prepare for this, you need to be organized. If I were back in the clinic today, here is the folder I would tell a patient to bring:
1. Your Detailed Treatment History
Don't just say "physio didn't work." Provide dates, the length of time you attended, and the specific feedback from the physiotherapist. If you tried medication, note the dosages and why you stopped (e.g., side effects or lack of efficacy).
2. The Specialist Letter
The most important document is a summary letter from your current neurologist. This should outline your MS subtype, your current disease-modifying therapies (DMTs), and your spasticity management history.
3. Clearly Defined Goals
Specialists want to know: "What will success look like?" Instead of saying "I want less pain," try "I want to be able to walk to the end of the street without my legs locking up."
Summary Table: Conventional Care vs. Specialist Assessment
Factor Conventional Pathway (NHS) Specialist Cannabis Assessment Primary Focus Standard NICE guidelines Clinical judgement/Personalised risk Evidence Required Diagnostic confirmation Documented failure of 2+ treatments Treatment Goal Manage symptoms/slow progression Specific symptomatic relief Decision Maker GP/Local Neurologist Specialist ConsultantManaging Expectations: Avoiding the "Overpromised Outcome"
I get annoyed when I see clinics imply that medical cannabis will "cure" your spasticity. It won't. In MS, it is a tool for management, not a silver bullet. If a provider guarantees success, they are ignoring the reality of chronic neurological conditions.
Furthermore, NICE currently provides specific guidance regarding Sativex (a cannabis-based spray) for MS spasticity in the NHS. If you have not tried Sativex, a private specialist is almost certainly going to ask why, or suggest you try it before looking at other cannabis-based products like oils or flower. This is because Sativex has the strongest clinical evidence-based backing for your specific condition.
Final Thoughts: How to Approach Your Next Step
If you are struggling with spasticity and feel like you have run out of options, you are not alone. However, don't rush into a private prescription before you have the paperwork to back up your journey. Here is my advice as a former admin:
- Gather your records: Request your "Summary Care Record" or a history of consultations from your GP surgery. Talk to your Neurologist: Ask them directly, "What is left on the NICE guidelines for spasticity that I haven't tried yet?" Check for Specialist GMC Status: Before you book a private consultation, look up the clinician on the GMC register to confirm they are a specialist in Neurology or Palliative Care.
You deserve to have all options on the table, but remember that the most effective way to be taken seriously by a specialist is to show them medical cannabis for psoriasis and inflammation that you have already exhausted the conventional, evidence-based route. Take your time, get your documentation in order, and focus on specialists who prioritize your overall safety over a quick prescription.